$40.16
arrow_drop_up0.32%There's no data available for key stats
There's no data available for ratios/profitability stats
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Calliditas Therapeutics takes certain corporate actions following announcement by Asahi Kasei
Critical Insights From Calliditas Therapeutics Analyst Ratings: What You Need To Know
Apple To Rally Over 47%? Here Are 10 Top Analyst Forecasts For Friday
Xencor (XNCR) Moves 14.3% Higher: Will This Strength Last?
Novartis (NVS) Presents Positive Data on Rare Kidney Disease Drug
Palo Alto Networks Issues Weak Outlook, Joins Teladoc Health, SolarEdge Technologies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session